Peppermint oil, in capsules that survive the stomach, relaxes gut muscle and quietens the nerves reporting pain. The most substantial claims cover irritable bowel syndrome and indigestion, though the most carefully designed recent trials matched a dummy treatment; nausea, headache and feeling cooler in heat rest on weaker evidence. Heartburn dominates the harms. (Full Review)

Protocol

Standard gastroenterology protocol

180–200 mg, three times daily

Enteric-coated, taken before breakfast, lunch and the evening meal; four-to-twelve-week course

Integrative and European alternative

90 mg peppermint + 50 mg caraway, twice daily

Fixed peppermint-plus-caraway oil combination used for indigestion

Topical headache protocol

10% solution in ethanol

Applied to forehead and temples at onset, repeated at 15 and 30 minutes

Time to effect

Irritable bowel syndrome

2–4 weeks

Primary endpoints measured at four weeks; some relief within days

Functional dyspepsia

4 weeks

Global dyspepsia symptoms assessed at four weeks

Tension-type headache

15 minutes

Intensity falls from 15 minutes after application

Benefits

High: Relief of irritable bowel syndrome symptoms; relief of functional dyspepsia symptoms

Medium: Reduced colonic spasm during endoscopy; reduction of treatment-related nausea; acute tension-type headache relief; reduced perceived thermal strain during exercise in heat

Low: Modest systolic blood pressure reduction; improved alertness and sustained attention from aroma

Speculative: Antimicrobial and oral-health effects; topical promotion of hair growth

Contraindications

Achalasia or severe erosive reflux (Los Angeles grade C or D)

Biliary obstruction, acute cholangitis or symptomatic gallstones

IgE-mediated allergy to peppermint, menthol or other Lamiaceae

Infants and children under 8 years (menthol near the face; oral capsules outside a trial)

Severe hepatic impairment (Child-Pugh Class C)

Key Interactions

CYP3A4 substrates (felodipine, simvastatin, tacrolimus)

Ciclosporin specifically

Proton pump inhibitors and H2 blockers (omeprazole)

Antacids (calcium carbonate, magnesium hydroxide)

Iron supplements (ferrous sulfate)

Additive supplement effects (magnesium, garlic, beetroot nitrate)

Other interventions (antispasmodics such as hyoscine)

Risk & Side Effects

High: Gastro-oesophageal reflux and heartburn

Medium: CYP3A4 inhibition and raised drug exposure; perianal and oral burning

Low: Contact dermatitis and chemical burn; IgE-mediated allergy and anaphylaxis; pulegone and menthofuran toxicity at high doses; reduced non-haem iron absorption from peppermint tea

Speculative: Laryngospasm and apnoea in infants

Monitoring

Marker	Target	Why
IBS-SSS score	Under 75 remission; 75–174 mild	Defines whether the course worked
Reflux symptom score	No established target; change from own baseline	Detects the commonest adverse effect
Alanine aminotransferase (ALT)	10–25 U/L men, 10–20 U/L women	Screens for the hepatic effect attributed to pulegone
Ferritin	50–150 ng/mL men, 40–100 ng/mL women	Catches iron depletion from habitual peppermint tea
Resting blood pressure	Under 120/80 mmHg	Tracks the modest hypotensive signal reported in one trial

Cadence: Reassessment at 2, 4 and 12 weeks; laboratory work every 6–12 months, or sooner with daily peppermint tea

Qualitative Assessment

Abdominal pain frequency and intensity, and whether cramping episodes shorten
Bloating and visible distension through the day
Bowel habit: stool form, urgency and sense of complete evacuation
Heartburn, acid taste and burning on defecation, as early intolerance signals
Daytime alertness and concentration, if peppermint aroma is used deliberately
Sleep continuity, particularly whether night-time reflux is waking sleep

Peppermint for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment